S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

KURA Kura Oncology Inc

7.57

-0.14 (-1.82%)

Last Updated: 09:00:58

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Kura Oncology (NASDAQ:KURA)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Kura Oncology Charts.

Kura Oncology (NASDAQ:KURA)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Kura Oncology Charts.

Kura Oncology Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 28 February 2025 (3 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 28 February 2025 (3 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 26 February 2025 (5 days ago) • Edgar (US Regulatory)

Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results
Wednesday 26 February 2025 (5 days ago) • GlobeNewswire Inc.

Kura Oncology to Participate in Three Upcoming Investor Conferences
Tuesday 25 February 2025 (6 days ago) • GlobeNewswire Inc.

Kura Oncology to Report Fourth Quarter and Full Year 2024 Financial Results
Wednesday 19 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 13 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 7 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 5 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
Wednesday 5 February 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 28 January 2025 (1 month ago) • Edgar (US Regulatory)

More Kura Oncology Inc News Articles

NioCorp Developments

Good Vibrations Shoes (PK)

RespireRx Pharmaceuticals (CE)

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Asia Broadband (PK)

Rennova Health (CE)

Code Green Apparel (PK)

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions